Global depression in breast cancer patients: Systematic review and meta-analysis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
27
08
2022
accepted:
05
06
2023
medline:
28
7
2023
pubmed:
26
7
2023
entrez:
26
7
2023
Statut:
epublish
Résumé
Breast cancer is known as one of the most common diseases among women, the psychological consequences of which are common in women and affect various aspects of their lives, so this study aims to investigate the prevalence of depression among women with breast cancer globally. The present meta-analysis was performed by searching for keywords related to breast cancer and depression in 4 main databases: PubMed, Embase, Web of Sciences and Scopus in the period of January 2000 to November 2021 and the results of the study using R and CMA software were analyzed. A total of 71 studies were selected in English and the results of the analysis showed that the prevalence of depression in women with breast cancer is 30.2%, with Pakistan having the highest (83%) prevalence of depression and Taiwan having the lowest (8.3%). And in the WHO regions, EMRO region had the highest (49.7%) rate and SEARO region had the lowest (23%) prevalence of depression. Also, with increasing age, the prevalence of depression among women with breast cancer increases. Community and family support for women with breast cancer, holding psychology and psychotherapy courses, lifestyle modifications and training in this area can be effective in preventing the reduction of the prevalence of depression, and given the pivotal role of women in family affairs, this This can be in line with the work of health system policymakers.
Sections du résumé
BACKGROUND
Breast cancer is known as one of the most common diseases among women, the psychological consequences of which are common in women and affect various aspects of their lives, so this study aims to investigate the prevalence of depression among women with breast cancer globally.
METHOD
The present meta-analysis was performed by searching for keywords related to breast cancer and depression in 4 main databases: PubMed, Embase, Web of Sciences and Scopus in the period of January 2000 to November 2021 and the results of the study using R and CMA software were analyzed.
RESULTS
A total of 71 studies were selected in English and the results of the analysis showed that the prevalence of depression in women with breast cancer is 30.2%, with Pakistan having the highest (83%) prevalence of depression and Taiwan having the lowest (8.3%). And in the WHO regions, EMRO region had the highest (49.7%) rate and SEARO region had the lowest (23%) prevalence of depression. Also, with increasing age, the prevalence of depression among women with breast cancer increases.
CONCLUSION
Community and family support for women with breast cancer, holding psychology and psychotherapy courses, lifestyle modifications and training in this area can be effective in preventing the reduction of the prevalence of depression, and given the pivotal role of women in family affairs, this This can be in line with the work of health system policymakers.
Identifiants
pubmed: 37494393
doi: 10.1371/journal.pone.0287372
pii: PONE-D-22-23966
pmc: PMC10370744
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0287372Informations de copyright
Copyright: © 2023 Javan Biparva et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
BMC Cancer. 2019 Aug 27;19(1):836
pubmed: 31455282
Caspian J Intern Med. 2014 Summer;5(3):167-70
pubmed: 25202445
Indian J Palliat Care. 2017 Jul-Sep;23(3):268-273
pubmed: 28827929
J Pain Symptom Manage. 2017 Mar;53(3):551-560
pubmed: 28042070
Cancer Manag Res. 2012;4:61-5
pubmed: 22427732
Breast Cancer Res Treat. 2008 Jul;110(1):9-17
pubmed: 17674188
Cochrane Database Syst Rev. 2013 Jun 04;(6):CD004253
pubmed: 23737397
Asian Pac J Cancer Prev. ;18(7):1889-1896
pubmed: 28749617
Health Psychol. 2004 Jan;23(1):3-15
pubmed: 14756598
Pain Res Treat. 2012;2012:851276
pubmed: 23227331
J Cancer Surviv. 2013 Sep;7(3):292-9
pubmed: 23471730
Sleep Med Clin. 2008 Mar;3(1):61-71
pubmed: 18769530
Patient Educ Couns. 2000 Jun;40(3):209-17
pubmed: 10838000
PLoS One. 2015 Jun 02;10(6):e0129169
pubmed: 26035180
PLoS One. 2018 Mar 07;13(3):e0193713
pubmed: 29513716
BMC Psychiatry. 2020 Mar 23;20(1):131
pubmed: 32293366
Int J Cancer. 2017 Feb 15;140(4):841-852
pubmed: 27859142
J Clin Oncol. 2000 Feb;18(4):743-53
pubmed: 10673515
Psychooncology. 2012 Jun;21(6):675-9
pubmed: 21462281
Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1495-506
pubmed: 26359465
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Eur J Oncol Nurs. 2017 Jun;28:47-55
pubmed: 28478855
J Natl Cancer Inst Monogr. 2004;(32):57-71
pubmed: 15263042
Psychooncology. 2018 Oct;27(10):2508-2510
pubmed: 29932279
Lancet Psychiatry. 2014 Oct;1(5):343-50
pubmed: 26360998
J Pak Med Assoc. 2013 Jan;63(1):69-71
pubmed: 23865135
Breast Cancer Res Treat. 2019 Aug;176(3):519-533
pubmed: 31087199
Asian Pac J Cancer Prev. 2014;15(24):10631-6
pubmed: 25605151
Psychooncology. 2018 Mar;27(3):908-914
pubmed: 29178147
Asian J Psychiatr. 2016 Oct;23:95-98
pubmed: 27969088
Asian Pac J Cancer Prev. 2013;14(4):2649-56
pubmed: 23725190
J Natl Compr Canc Netw. 2007 Jan;5(1):3-7
pubmed: 17323529
J Occup Rehabil. 2017 Dec;27(4):547-558
pubmed: 27858198
Neuropsychiatr Dis Treat. 2017 Sep 13;13:2389-2396
pubmed: 28979126
Cancer. 2006 Dec 15;107(12):2924-31
pubmed: 17103381
Asian Pac J Cancer Prev. 2015;16(9):4031-5
pubmed: 25987081
Psychooncology. 2017 Jan;26(1):133-136
pubmed: 26872293
Psychol Med. 2011 Jul;41(7):1429-36
pubmed: 20942992
Adv Nutr. 2016 Mar 15;7(2):418-9
pubmed: 26980827
Soc Sci Med. 2017 Nov;192:134-142
pubmed: 28965004
Eur J Cancer. 2004 Jul;40(11):1689-95
pubmed: 15251158
Int J Med Inform. 2019 May;125:102-109
pubmed: 30914174
J Womens Health (Larchmt). 2012 Mar;21(3):311-8
pubmed: 22060256
Asian Pac J Cancer Prev. ;18(10):2809-2816
pubmed: 29072421
Soc Psychiatry Psychiatr Epidemiol. 2010 Mar;45(3):355-61
pubmed: 19458878
Psychooncology. 2014 Feb;23(2):121-30
pubmed: 24105788
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Surg. 2021 Apr;88:105906
pubmed: 33789826
Psychooncology. 2018 Mar;27(3):1013-1020
pubmed: 29226996
J Med Assoc Thai. 2007 Oct;90(10):2164-74
pubmed: 18041438